Dysregulation of innate immune signaling in animal models of spinal muscular atrophy

2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background: Spinal muscular atrophy (SMA) is a devastating neuromuscular disease caused by hypomorphic loss of function in the survival motor neuron (SMN) protein. SMA presents across a broad spectrum of disease severity. Unfortunately, genetic models of intermediate SMA have been difficult to generate in vertebrates and are thus unable to address key aspects of disease etiology. To address these issues, we developed a Drosophila model system that recapitulates the full range of SMA severity, allowing studies of pre-onset biology as well as late-stage disease processes. Results: Here, we carried out transcriptomic and proteomic profiling of mild and intermediate Drosophila models of SMA to elucidate molecules and pathways that contribute to the disease. Using this approach, we elaborated a role for the SMN complex in the regulation of innate immune signaling. We find that mutation or tissue-specific depletion of SMN induces hyperactivation of the immune deficiency (IMD) and Toll pathways, leading to overexpression of antimicrobial peptides (AMPs) and ectopic formation of melanotic masses in the absence of an external challenge. Furthermore, the knockdown of downstream targets of these signaling pathways reduced melanotic mass formation caused by SMN loss. Importantly, we identify SMN as a negative regulator of a ubiquitylation complex that includes Traf6, Bendless, and Diap2 and plays a pivotal role in several signaling networks. Conclusions: In alignment with recent research on other neurodegenerative diseases, these findings suggest that hyperactivation of innate immunity contributes to SMA pathology. This work not only provides compelling evidence that hyperactive innate immune signaling is a primary effect of SMN depletion, but it also suggests that the SMN complex plays a regulatory role in this process in vivo. In summary, immune dysfunction in SMA is a consequence of reduced SMN levels and is driven by cellular and molecular mechanisms that are conserved between insects and mammals.

References Powered by Scopus

Near-optimal probabilistic RNA-seq quantification

5670Citations
N/AReaders
Get full text

Identification and characterization of a spinal muscular atrophy-determining gene

3401Citations
N/AReaders
Get full text

The host defense of Drosophila melanogaster

2732Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Balancing RNA processing and innate immune response: Possible roles for SMN condensates in snRNP biogenesis

0Citations
N/AReaders
Get full text

Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Garcia, E. L., Steiner, R. E., Raimer, A. C., Herring, L. E., Matera, A. G., & Spring, A. M. (2024). Dysregulation of innate immune signaling in animal models of spinal muscular atrophy. BMC Biology, 22(1). https://doi.org/10.1186/s12915-024-01888-z

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

38%

Researcher 3

38%

Professor / Associate Prof. 2

25%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

50%

Medicine and Dentistry 2

25%

Agricultural and Biological Sciences 1

13%

Neuroscience 1

13%

Article Metrics

Tooltip
Mentions
News Mentions: 2

Save time finding and organizing research with Mendeley

Sign up for free